Factors Affecting Medication Adherence among Nepalese Hypertensives in a Rural Area
Keywords:
Medication adherence, Hypertension, Community based, Rural, Patient-related factorsAbstract
Maintaining drug adherence has become a challenge for both the hypertensives and the health system for a variety of reasons. There is a lack of understanding about the several factors that may lead to medication non-adherence, especially among rural hypertensives. The purpose of this study was to assess the status of medication adherence and to identify the factors influencing medication adherence among Nepalese rural hypertensives. This community-based cross-sectional study was conducted among 405 rural hypertensives from Lamahi Municipality, Dang District of Nepal through a simple random sampling. The sample size for this study was determined using the formula: Z2pq/d2. The standard 9-items Hill-Bone medication scale (HB-MAS) questionnaire was used to assess the status of medication adherence. The questionnaires used in this study are based on rigorous literature review and were tested for the validity and reliability. Data was collected using a face-to-face interview and was analyzed using descriptive (frequency and proportion), bivariate (chi-square) and multiple logistic regression. Study indicated that only 56.5% hypertensives are adherent to antihypertensive medication. Ethnicity [adjusted odds ratio (AOR) = 0.24; 95% CI: 0.09 - 0.65, p 0.005], knowledge [AOR = 13.80; 95% CI: 4.95 – 38.48, p <0.001], attitude [AOR = 15.08; 95% CI: 5.21 – 43.63, p <0.001], availability of medication and services [AOR = 2.84; 95% CI: 1.24 - 6.49, p <0.013], and accommodation of hypertension-related services [AOR = 14.15; 95% CI: 2.21 – 90.57, p 0.005] are the factors associated with medication adherence. Targeting tailored interventions for specific ethnic groups, enhancing knowledge, and building trust among the hypertensives regarding the medication, ensuring availability of the antihypertensive medication, and strengthening current health service provision for antihypertensive medication and services closer to the communities might improve medication adherence among the rural hypertensives in Nepal.
References
Burnier M, Egan BM. Adherence in hypertension: A review of prevalence, risk factors, impact, and management. Circulation Research. 2019 Mar 29;124(7):1124-40. DOI: 10.1161/CIRCRESAHA.118.313220
Burnier M, Wuerzner G, Struijker-Boudier H, Urquhart J. Measuring, analyzing, and managing drug adherence in resistant hypertension. Hypertension. 2013 Aug; 62(2): 218-25. DOI: 10.1161/HYPERTENSIONAHA.113.00687
World Health Organization. Hypertension Factsheet. Available from: https://www.who.int/news-room/fact-sheets/detail/hypertension, access 18 October, 2022
World Health Organization. Nepal hypertension factsheet. 2019. Available from: https://cdn.who.int/media/docs/default-source/country-profiles/hypertension/npl_en.pdf?sfvrsn=2c2ad0ce_9&download=true, accessed 8 January, 2022
Shrestha P, Wattanakitkrileart D, Pongthavornkamol K. Factors influencing medication adherence in Nepalese patients with essential hypertension. Nursing Science Journal of Thailand. 2019 Sep 23; 37(3): 18-31.
Dhar L, Earnest J, Ali M. A systematic review of factors influencing medication adherence to hypertension treatment in developing countries. Open J Epidemiol. 2017; 7(03): 211-50. DOI:10.4236/ojepi.2017.73018
Roka T, Ghimire M. Medication adherence among hypertensive patients attending a tertiary care hospital in Nepal. J Nepal Health Res Counc. 2019; 17(4): 521-7. DOI: 10.33314/jnhrc.v17i4.2337
Khanal GN, Bharadwaj B, Upadhyay N, Bhattarai T, Dahal M, Khatri RB. Evaluation of the national health insurance program of Nepal: are political promises translated into actions?. Health Res. Policy Syst. 2023 Dec; 21(1): 1-26. DOI: 10.1186/s12961-022-00952-w
Thapa R, Bam K, Tiwari P, Sinha TK, Dahal S. Implementing federalism in the health system of Nepal: opportunities and challenges. Int J Health Policy Manag. 2019 Apr; 8(4): 195. DOI: 10.15171/ijhpm.2018.121
World Health Organization. Regional Office for South-East Asia. Monitoring progress on universal health coverage and the health-related sustainable development goals in the WHO South-East Asia Region: 2019 update. 2019. Available from: https://apps.who.int/iris/handle/10665/326828
Garha M. Health care in Nepal: An observational perspective. J Nurs Educ Pract. 2017; 7(1): 114-7. DOI: 10.5430/jnep.v7n1p114
Mendis S, Fukino K, Cameron A, Laing R, Filipe Jr A, Khatib O, et al. The availability and affordability of selected essential medicines for chronic diseases in six low-and middle-income countries. Bull World Health Organ. 2007 Apr; 85(4):279-88. DOI: 10.2471/blt.06.033647
Ewen M, Zweekhorst M, Regeer B, Laing R. Baseline assessment of WHO’s target for both availability and affordability of essential medicines to treat non-communicable diseases. PloS One. 2017 Feb 7; 12(2): e0171284. DOI: 10.1371/journal.pone.0171284
Khadka S, Maharjan A, Bhardwaj M, Jha A, Bajracharya M, Lamichhane B. Adherence to anti-hypertensive medications among patients in selected health facilities of Nepal. J Nepal Health Res Counc. 2021 Apr 23; 19(1): 83-6. DOI: 10.33314/jnhrc.v19i1.1395
Shakya R, Shrestha S, Gautam R, Rai L, Maharjan S, Satyal GK, et al. Perceived illness and treatment adherence to hypertension among patients attending a tertiary hospital in Kathmandu, Nepal. Patient Prefer Adherence. 2020 Nov 20: 2287-300. DOI: 10.2147/PPA.S270786
Shrestha TM, Bhusal L, Raut S, Ghimire R, Shrestha P. Factors associated with non-adherence to antihypertensive medication among hypertensive patients in community. Journal of Karnali Academy of Health Sciences. 2019 Jun 6; 2(1). DOI: 10.2147/PPA.S238751
Hassanein M. Adherence to antihypertensive fixed-dose combination among Egyptian patients presenting with essential hypertension. Egypt Heart J. 2020 Dec; 72(1): 1-9. DOI: 10.1186/s43044-020-00044-6
Alsofyani MA, Aloufi AO, Al-Qhtani NS, Bamansour SO, Almathkori RS. Factors related to treatment adherence among hypertensive patients: A cross-sectional study in primary healthcare centers in Taif city. J Family Community Med. 2022 Sep 1; 29(3):181-8. DOI: 10.4103/jfcm.jfcm_153_22
Haga SB, Orlando LA. Expanding family health history to include family medication history. J Pers Med 2023 Feb 25; 13(3): 410. DOI: 10.3390/jpm13030410
Zhang Y, Li X, Mao L, Zhang M, Li K, Zheng Y, Cui W, et al. Factors affecting medication adherence in community-managed patients with hypertension based on the principal component analysis: Evidence from Xinjiang, China. Patient Prefer Adherence. 2018 May 11: 803-12. DOI: 10.2147/PPA.S158662
Shaw R, Bosworth HB. Baseline medication adherence and blood pressure in a 24‐month longitudinal hypertension study. J Clin Nurs. 2012 May; 21(9‐10): 1401-6. DOI: 10.1111/j.1365-2702.2011.03859.x
Green LW, Kreuter MW. Health program planning: an educational and ecological approach. 4 New York; 2005.
Lwanga SK, Lemeshow S, World Health Organization. Sample size determination in health studies: A practical manual. World Health Organization; 1991.
Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the hill‐bone compliance to high blood pressure therapy scale. Prog Cardiovasc Nurs. 2000 Jun; 15(3): 90-6. DOI: 10.1111/j.1751-7117.2000.tb00211.x
Lambert EV, Steyn K, Stender S, Everage N, Fourie JM, Hill M. Cross-cultural validation of the hill-bone compliance to high blood pressure therapy scale in a South African, primary healthcare setting. Ethnicity & Disease. 2006; 16(1): 286–91.
Krathwohl DR. A revision of Bloom's taxonomy: An overview. Theory into practice. 2002 Nov 1; 41(4): 212-8. DOI: 10.1207/s15430421tip4104_2
McLaughlin CG, Wyszewianski L. Access to care: remembering old lessons. Health services research. 2002 Dec 1; 37(6): 1441-3. DOI: 10.1111/1475-6773.12171
Algabbani FM, Algabbani AM. Treatment adherence among patients with hypertension: findings from a cross-sectional study. Clinical hypertension. 2020 Dec; 26(1): 1-9. DOI: 10.1186/s40885-020-00151-1
Shi S, Shen Z, Duan Y, Ding S, Zhong Z. Association between medication literacy and medication adherence among patients with hypertension. Front Pharmacol. 2019 Jul 19; 10: 822. DOI: 10.3389/fphar.2019.00822
Hashmi SK, Afridi MB, Abbas K, Sajwani RA, Saleheen D, Frossard PM, et al. Factors associated with adherence to anti-hypertensive treatment in Pakistan. PLOS ONE. 2007 Mar 14; 2(3): e280. DOI: 10.1371/journal.pone.0000280
Khan MU, Shah S, Hameed T. Barriers to and determinants of medication adherence among hypertensive patients attended National Health Service Hospital, Sunderland. J Pharm Bioallied Sci. 2014 Apr 1; 6(2): 104. DOI: 10.4103/0975-7406.129175
Safford MM, Halanych JH, Lewis CE, Levine D, Houser S, Howard G. Understanding racial disparities in hypertension control. Ethnicity & disease. 2007 Jul 1; 17(3): 421-6. DOI: 10.1007/s11886-022-01826-x
Dong X, Tsang CC, Wan JY, Shih YC, Chisholm-Burns MA, Dagogo-Jack S, et al. Exploring racial and ethnic disparities in medication adherence among medicare comprehensive medication review recipients. Explor Res Clin Soc Pharm. 2021 Sep 1; 3: 100041. DOI: 10.1016/j.rcsop.2021.100041
Liu Q, Quan H, Chen G, Qian H, Khan N. Antihypertensive medication adherence and mortality according to ethnicity: A cohort study. Can J Cardiol. 2014 Aug 1; 30(8): 925-31. DOI: 10.1016/j.cjca.2014.04.017
Edward A, Campbell B, Manase F, Appel LJ. Patient and healthcare provider perspectives on adherence with antihypertensive medications: An exploratory qualitative study in Tanzania. BMC Health Serv Res. 2021 Dec; 21(1): 1-2. DOI: 10.2147/PPA.S328785
Thresia CU, Srinivas PN, Mohindra KS, Jagadeesan CK. The health of Indigenous populations in South Asia: A critical review in a critical time. Int J Health Serv. 2022 Jan; 52(1): 61-72. DOI: 10.1177/0020731420946588
Odusola AO, Hendriks M, Schultsz C, Bolarinwa OA, Akande T, Osibogun A, et al. Perceptions of inhibitors and facilitators for adhering to hypertension treatment among insured patients in rural Nigeria: a qualitative study. BMC Health Serv Res. 2014 Dec; 14(1): 1-6. DOI: 10.1186/s12913-014-0624-z
Lubaki JP, Mabuza L, Malete N, Ndimande JV, Maduna P. Reasons for non-compliance among patients with hypertension at Vanga Hospital, Bandundu Province, Democratic Republic of Congo: A qualitative study. Afr J Prim Health Care Fam Med. 2009 Jan 1; 1(1): 1-5. DOI: 10.4102/phcfm.v1i1.68
Wahyuni AS, Mukhtar Z, Pakpahan DJ, Guhtama MA, Diansyah R, Situmorang NZ, et al. Adherence to consuming medication for hypertension patients at primary health care in medan city. Open Access Maced J Med Sci. 2019 Oct 10;7 (20): 3483. DOI: 10.3889/oamjms.2019.683
Kumar Praveen N, Halesh L. Antihypertensive treatment: A study on correlates of non adherence in a tertiary care facility. Int J Biol Med Res. 2010; 1(4): 248-52.
Hareri HA, Gedefaw M, Simeng B. Assessment of prevalence and associated factors of adherence to anti-hypertensive agents among adults on follow up in Adama Referal hospital, East Shoa, Ethiopia-cross sectional study. Int J Curr Microbiol Appl Sci. 2014; 3(1): 760-0.
Rampamba EM, Meyer JC, Helberg E, Godman B. Medicines availability among hypertensive patients in primary health care facilities in a rural province in South Africa: Findings and implications. J Res Pharm Pract. 2020 Oct; 9(4): 181. DOI: 10.4103/jrpp.JRPP_20_49
Ramli A, Ahmad NS, Paraidathathu T. Medication adherence among hypertensive patients of primary health clinics in Malaysia. Patient Prefer Adherence. 2012 Aug 31: 613-22. DOI: 10.2147/PPA.S34704
Kang CD, Tsang PP, Li WT, Wang HH, Liu KQ, Griffiths SM, et al. Determinants of medication adherence and blood pressure control among hypertensive patients in Hong Kong: a cross-sectional study. Int J Cardiol. 2015 Mar 1; 182: 250-7. DOI: 10.1016/j.ijcard.2014.12.064
Dhimal M, Bista B, Bhattarai S, Dixit LP, Hyder MK, Agrawal N, et al. Report of non communicable disease risk factors: STEPS survey Nepal 2019. Kathmandu: Nepal Health Research Council. 2020.
Akuiyibo S, Anyanti J, Amoo B, Aizobu D, Idogho O. Effects of behaviour change communication on hypertension and diabetes related knowledge, attitude and practices in Imo and Kaduna States: A quasi-experimental study. BMC Public Health. 2022 Apr 11; 22(1): 715. DOI: 10.1186/s12889-022-13139-3
Attaei MW, Khatib R, McKee M, Lear S, Dagenais G, Igumbor EU, et al. Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: An analysis of the PURE study data. Lancet Public Health. 2017 Sep 1; 2(9): e411-9. DOI: 10.1016/S2468-2667(17)30141-X
Ministry of Health and Population. Department of Drug Administration. National List of Essential Medicines Nepal Sixth Revision. Nepal: 2011. Available from: https://www.dda.gov.np/content/essential-drug-list
Choudhry NK, Kronish IM, Vongpatanasin W, Ferdinand KC, Pavlik VN, Egan BM, et al. Medication adherence and blood pressure control: a scientific statement from the American Heart Association. Hypertension. 2022 Jan; 79(1): e1-4. DOI: 10.1161/HYP.0000000000000203
Edward A, Campbell B, Manase F, Appel LJ. Patient and healthcare provider perspectives on adherence with antihypertensive medications: An exploratory qualitative study in Tanzania. BMC Health Serv Res. 2021 Dec; 21(1): 1-2.
Robinson JH, Callister LC, Berry JA, Dearing KA. Patient‐centered care and adherence: Definitions and applications to improve outcomes. J Am Acad Nurse Pract. 2008 Dec; 20(12): 600-7. DOI: 10.1111/j.1745-7599.2008.00360.x
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Creative Commons License CC-BY-ND
